Developing drugs targeting CX3CL1 to treat heart diseases via immune/inflammatory mediation.
作者信息
Zou Lin, Ma Junhua, Hu Guiying, Zhu Hongling, Zhang Lijuan, Li Xiangqi
机构信息
Department of Endocrinology and Metabolism, Gongli Hospital, Naval Medical University, Shanghai 200135, China.
Outpatient Department, Zhongxian People's Hospital, Chongqing 404300, China.
出版信息
Acta Biochim Biophys Sin (Shanghai). 2023 Oct 25;55(10):1672-1676. doi: 10.3724/abbs.2023157.
Abstract
摘要
Zotero 插件